S&P 500
$5,802.82
-0.7%
-$39.19
DJI
$41,603.07
-0.6%
-$256.02
NASDAQ
$18,737.21
-1.0%
-$188.53
Bitcoin
107,810.00
+0.2%
+194.54
AAPL
$195.55
-2.9%
-$5.81
AMZN
$201.33
-0.9%
-$1.77
GOOG
$169.68
-1.3%
-$2.30
META
$627.70
-1.4%
-$8.87
MSFT
$451.11
-0.8%
-$3.75
NVDA
$131.48
-1.0%
-$1.36
TSLA
$339.93
-0.3%
-$1.11
Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights
Apr 19, 2025
by Keith Speights
3 Vanguard ETFs to Buy With $500
Apr 18, 2025
by Keith Speights
Where Will Eli Lilly Be in 5 Years?
Apr 14, 2025
by Keith Speights
Is Iovance Biotherapeutics a Millionaire-Maker?
Apr 13, 2025
by Keith Speights
41 States That Don't Tax Social Security Benefits
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.